   |
|
|
|
|
| The OTC Report Issues Update on Pediatric Prosthetics Inc.<
OTC Report Reiterates Pediatric Prosthetics Inc. (OTC: PDPR) with a Buy Rating and announces that Linda Putback-Bean, co-founder and president of Pediatric Prosthetics Inc., is the premier upper extremity specialist fighting for the rights of children with a prosthetic need. Today, Linda is recognized as the leading prosthetist in the infant- pediatric prosthetic field. She has been featured in her industry's leading trade journal, "Orthotics & Prosthetics Business News." In addition to having been written up in "Life Magazine," Linda and the children she has fitted have appeared on numerous national TV shows, including "Good Morning America," "Maury Povich," "Phil Donahue," and "20-20," with Barbara Walters. Serious & personalized business, investment and technology intelligence for a serious advantage - BizVantage! With Linda's expertise and dedication, Pediatric Prosthetics Inc. plans to dominate the fragmented children's prosthetics business. This over-looked segment of the prosthetics industry represents an opportunity to directly affect the lives of thousands of children and their parents in a way that has never been done before. Pediatric Prosthetics Inc., based in Houston, Texas, is the primary provider of prosthetic patient care specializing in the infant-pediatric market on a national scale. The Company will focus on both the physical needs of the children and the emotional support to their parents. Other active stocks were: The St. Paul Companies (NYSE: SPC) Up 2.6% 10M shares, Arotech Corp. (NASDAQ: ARTX) Up 11% on 3.7M shares and NTL Inc. (NASDAQ: NTLIR) Up 16% on 2.4M shares. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. The OTC Report accepts no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party consultant has hired and paid the OTC Report $666.66 for the publication and circulation of this report. As always do your own due diligence. Our technical analysis may from time to time cause the target price to fluctuate without notice. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. The OTC Report has no ownership of equity and no representation of accuracy in the above company and our reports are designed to communicate company communications through our Press Release Service. C.P. Barry OTC Report 1.888.478.7669 or 570.722.4098
|
